BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FORTREATING METABOLIC DISORDERS

Details for Australian Patent Application No. 2003262916 (hide)

International Classifications

Event Publications

11 December 2003 Complete Application Filed

Priority application(s): 10/230,084 29.08.02 US

6 May 2004 Application Open to Public Inspection

Published as AU-A-2003262916

2 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 August 2005 Section 223 Application Allowed

Novadel Pharma Inc. The time in which to enter the National Phase has been extended to 29 Apr 2005. Address for service in Australia - Allens Arthur Robinson The Chifley Tower 2 Chifley Square SYDNEY NSW 2000

24 November 2005 Assignment before Grant

Novadel Pharma Inc The application has been assigned to Velcera Pharmaceuticals, Inc

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.